200
Participants
Start Date
January 14, 2020
Primary Completion Date
February 22, 2021
Study Completion Date
March 1, 2021
Exalt Model D Single-Use Duodenoscope
Subjects will have a clinically indicated per standard of care endoscopic retrograde cholangiopancreatography (ERCP) or other duodenoscope-based procedure performed with the Exalt single use duodenoscope study device.
North Shore University Hospital, Manhasset
University of Pittsburgh Medical Center, Pittsburgh
Mayo Clinic, Rochester
University of California Los Angeles Medical Center, Los Angeles
Virginia Mason Medical Center, Seattle
Beth Israel Deaconess Medical Center, Boston
Erasmus Medical Center, Rotterdam
Lead Sponsor
Boston Scientific Corporation
INDUSTRY